Tang Rui, Wan Dongping, Leng Chuan, Fan Xiaohong, Li Yang, Ma Jianbing, Huang Yuanchi, Xu Chao
Department of Knee Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shanxi Province, People's Republic of China.
The Clinical Medical College, Chengdu University of Chinese Traditional Medicine, Chengdu, Sichuan Province, People's Republic of China.
J Pain Res. 2024 Dec 14;17:4263-4276. doi: 10.2147/JPR.S499700. eCollection 2024.
This research aims to develop and validate the Chinese version of the Central Sensitization Inventory (CSI-CV) for patients suffering from chronic non-specific low back pain (CNSLBP). The study evaluates both the validity and reliability of the CSI-CV.
The cross-cultural adaptation of the scale strictly adhered to the principles of Bombardier and Beaton. Initially, two professors of Chinese-English translation independently translated the original CSI scale into the target language, and then collaborated with an expert in cross-cultural adaptation to merge into a single version. This version was back-translated into English by two professors whose native language is English. Following this, the scale underwent preliminary review by bilingual experts and the research team, and was preliminarily tested, ultimately culminating in the formation of the CSI-CV version. A total of 310 patients with CNSLBP completed the CSI-CV, while 50 of them repeated the survey one week later to test the stability of the scale. The CSI-CV's reliability, validity, and internal consistency were assessed through exploratory factor analysis (EFA), correlation coefficients, and Cronbach's α.
EFA revealed five distinct factors from the 25 CSI-CV items, covering physical symptoms, emotional distress, fatigue and sleep disturbances, headaches and jaw symptoms, and urinary issues, with a total explained variance of 60.24%. The Cronbach's α was 0.910, and the intraclass correlation coefficient (ICC) was 0.924, indicating strong reliability. Moderate correlations were observed between CSI-CV scores and Five-Level EuroQol Five-Dimensional Questionnaire (r = -0.515), the Brief Pain Inventory (r = 0.586) and Oswestry Disability Index (r = 0.416), demonstrating significant associations with these measures.
The CSI-CV exhibits excellent internal consistency, factor structure, and reliability. Its successful cultural adaptation offers valuable insights for improving treatment approaches for patients with CNSLBP.
本研究旨在开发并验证适用于慢性非特异性下腰痛(CNSLBP)患者的中文版中枢敏化量表(CSI-CV)。该研究评估了CSI-CV的效度和信度。
该量表的跨文化改编严格遵循庞巴迪和比顿的原则。最初,两位汉英翻译教授独立将原始CSI量表翻译成目标语言,然后与一位跨文化改编专家合作合并成一个版本。该版本由两位以英语为母语的教授回译成英语。随后,该量表经过双语专家和研究团队的初步审查,并进行了预测试,最终形成了CSI-CV版本。共有310例CNSLBP患者完成了CSI-CV,其中50例在一周后重复调查以测试该量表的稳定性。通过探索性因素分析(EFA)、相关系数和克朗巴哈α系数评估CSI-CV的信度、效度和内部一致性。
EFA从25个CSI-CV项目中揭示了五个不同的因素,涵盖身体症状、情绪困扰、疲劳和睡眠障碍、头痛和下颌症状以及泌尿问题,总解释方差为60.24%。克朗巴哈α系数为0.910,组内相关系数(ICC)为0.924,表明信度较强。观察到CSI-CV得分与欧洲五维健康量表(r = -0.515)、简明疼痛量表(r = 0.586)和奥斯威斯功能障碍指数(r = 0.416)之间存在中度相关性,表明与这些测量方法有显著关联。
CSI-CV具有出色的内部一致性、因素结构和信度。其成功的文化改编为改善CNSLBP患者的治疗方法提供了有价值的见解。